Literature DB >> 15164177

Molecular pathology of renal cell carcinoma.

S Störkel1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164177     DOI: 10.1007/s00120-004-0593-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  15 in total

1.  Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.

Authors:  M R Speicher; B Schoell; S du Manoir; E Schröck; T Ried; T Cremer; S Störkel; A Kovacs; G Kovacs
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

2.  Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC).

Authors:  S Störkel; J N Eble; K Adlakha; M Amin; M L Blute; D G Bostwick; M Darson; B Delahunt; K Iczkowski
Journal:  Cancer       Date:  1997-09-01       Impact factor: 6.860

3.  Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.

Authors:  F Jiang; R Desper; C H Papadimitriou; A A Schäffer; O P Kallioniemi; J Richter; P Schraml; G Sauter; M J Mihatsch; H Moch
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

4.  Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype.

Authors:  A M Meloni; R M Dobbs; J E Pontes; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1993-01

5.  Renal oncocytoma with t(5;12;11), der(1)1;8) and add(19): "true" oncocytoma or chromophobe adenoma?

Authors:  T Dijkhuizen; E van den Berg; S Störkel; B de Vries; A Y van der Veen; M Wilbrink; A Geurts van Kessel; B de Jong
Journal:  Int J Cancer       Date:  1997-11-14       Impact factor: 7.396

6.  Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia.

Authors:  J R Toro; G Glenn; P Duray; T Darling; G Weirich; B Zbar; M Linehan; M L Turner
Journal:  Arch Dermatol       Date:  1999-10

7.  VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.

Authors:  H Brauch; G Weirich; J Brieger; D Glavac; H Rödl; M Eichinger; M Feurer; E Weidt; C Puranakanitstha; C Neuhaus; S Pomer; W Brenner; P Schirmacher; S Störkel; M Rotter; A Masera; N Gugeler; H J Decker
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

8.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

9.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

Review 10.  Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.

Authors:  J R Gnarra; M I Lerman; B Zbar; W M Linehan
Journal:  Semin Oncol       Date:  1995-02       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.